The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.

DexCom (NasdaqGS:DXCM) recently experienced a 14% price increase over the past week. This uptick coincides with the company's announcement of FDA clearance for the Dexcom G7 Continuous Glucose ...

What Johnson & Johnson and Eli Lilly are saying about Trump’s pharmaceutical tariffs, and Dexcom scores FDA approval for its ...

As per Vantage Market Research, the Global Hba1c Testing Device Market has been significantly growing over the years due to ...

The Diabetes Link organization organized a diabetes tech seminar that brought together individuals with Type 1 diabetes, ...